The scientists from the Research Council of the Supreme Science (CSIC) in Spain is testing a vaccine to prevent HIV, there has been very positive effect through volunteer participants in vaccine -please.
After a year of testing MVA-B vaccine in humans, 95% of 24 patients were able to generate immune system against viruses; 85% of them maintain this system in a year.
The principal use of vaccines is to stimulate the production of B lymphocytes - machine producing antibodies that attack HIV, preventing the virus to infect healthy cells.
Mariano Esteban, who led the research said: "Characteristics of the immune system MVA-B, initially achieved the necessary requirements for an effective vaccine against HIV. Although not remove virus from the body, the immune system response thanks to vaccines, thereby controlling the virus by attacking infected cells. "
The testing will continue in phase II and III to ensure real effectiveness and put into mass production.
The previous drug testing results only for about 25%. However, this vaccine strains with a specificity of HIV subtypes prevalent in Europe, South America and North America.
Không có nhận xét nào:
Đăng nhận xét